Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
about
Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsPancreatic Cancer, A Mis-interpreter of the Epigenetic LanguageThe Emerging Role of microRNAs in Schizophrenia and Autism Spectrum DisordersUnraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitorCirculating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsRegulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction.Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancerCandidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance.N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.miR-132/212 cluster inhibits the growth of lung cancer xenografts in nude mice.MiR-467a is upregulated in radiation-induced mouse thymic lymphomas and regulates apoptosis by targeting Fas and Bax.Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma.DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancerClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cellsDifferential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells.miR-212/132 expression and functions: within and beyond the neuronal compartment.Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate CellsMicroRNA-132 enhances transition from inflammation to proliferation during wound healing.MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression.Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancerRadiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cellsThe loop structure and the RNA helicase p72/DDX17 influence the processing efficiency of the mice miR-132.miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.Methylation-induced silencing of maspin contributes to the proliferation of human glioma cellsAberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor TissuesmiRNA regulation of Sirtuin-1 expression in human astrocytoma.Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.DNA methylation landscape of fat deposits and fatty acid composition in obese and lean pigs.Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
P2860
Q28074465-BF0FBF9F-0B6F-4E1F-BFC8-18237308A010Q28079735-B8E4711D-BBC8-4327-A5B7-2D592926AAE0Q28112165-FEE7168B-68D9-42C5-9417-1508EFD3EEC7Q28389159-A8EF3D07-1D9D-4AF2-8500-601BDB3B64FEQ30661625-1340DF5E-D9E4-40A5-9069-5141FDB1187BQ33687038-F725B2FE-F16C-4371-91DA-14903EFF9666Q33718281-4A6C7846-5E6D-4A58-9CF6-1F2FAB8C3BC7Q33801377-95C2683A-A53F-4676-BF33-94BCA4C6B66AQ33914260-F0D8866D-2CB6-4731-B1D9-632A2C06CEEFQ33948361-A857C127-2E83-458D-BF92-E1361BCED824Q33962495-8CC700A8-CE7C-4B63-A6D4-BBB921E2649AQ34047424-0E4119F1-9B09-43C7-A1B2-220BA569A4C5Q34093798-C64499F9-ACEA-4D0F-A808-B8530353AD52Q34249344-24BECF80-1A34-491C-9D15-9AB3395A0576Q34260260-F7F74D79-4940-4394-97D2-8D03382C73BFQ34769868-06C0FDE9-E77A-4049-B4D7-0765FA3EEE8DQ34780990-0E8F4092-9403-4A70-9B2C-5EF975FEC845Q35104047-4179BAFB-EF3D-4536-A0F8-94CF525863E8Q35120258-6BCD6655-BF9F-40E7-BB59-2C149DD9DC14Q35169860-CCB01D0E-B397-4D19-A7B0-830E7FBC2466Q35197356-5E12E75C-9330-4A1F-8918-BD239617F722Q35674826-BBC4D739-61A8-46D9-BE76-B7A9137198D1Q35735278-6C392368-0399-4A9A-8581-61E70F6AB6C0Q35878681-1EF718A1-D2F3-4C94-880F-376B41BC7D99Q35978278-7BCB5632-6E25-4E9F-B15C-DA3EB27C607FQ36008128-A97573A2-91B1-4BD6-B719-BB10C5490DA4Q36014262-1089AD51-9EFD-4836-A164-CC99691F6B6AQ36026774-228AAC97-8785-419B-B2B7-298831B06D29Q36040461-8C84141C-B153-480A-8D11-4B7689AFA9F9Q36309371-3634D50A-01F9-40B5-B9F1-F6AE6F83076EQ36365499-EBB93C9C-7C8C-4B10-8BBF-B616B83343F1Q36454693-2A240178-F4B2-4112-979C-99109AC69C1EQ36656875-3C6188A5-005E-4727-9FC3-BC599AB71B2CQ36878587-8765A986-B0F7-45A9-A42E-E84761F7B585Q36983836-C55D6827-25C9-423E-8062-419F73930453Q37056916-52AD381C-9EE5-45E1-B4BE-17028CBC3BC3Q37288313-6D8FF427-0ACC-415D-AA1B-3D129D82B21EQ37288584-BCDF7730-8D96-41F3-BAB1-1027D5B32873Q37323803-F3BBC3B5-D903-49D0-9945-8458F5256377Q37364111-1D0F88B0-2613-4C9D-92EC-08B92B8D218C
P2860
Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Downregulation of miR-132 by p ...... pancreatic cancer development.
@en
type
label
Downregulation of miR-132 by p ...... pancreatic cancer development.
@en
prefLabel
Downregulation of miR-132 by p ...... pancreatic cancer development.
@en
P2093
P356
P1433
P1476
Downregulation of miR-132 by p ...... pancreatic cancer development.
@en
P2093
Chenghao Shao
Jinchang Wu
Jundong Zhou
Shuyu Zhang
Xiangui Hu
P304
P356
10.1093/CARCIN/BGR105
P407
P577
2011-06-10T00:00:00Z